Related references
Note: Only part of the references are listed.Side effects of atypical antipsychotics: a brief overview
ALP ÜÇOK et al.
World Psychiatry (2015)
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone
Siti Norsyuhada Roffeei et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia
Umarat Srisawat et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances
A. C. C. Kao et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study
Emily C. Shing et al.
NEUROPSYCHOBIOLOGY (2014)
Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
Siti Norsyuhada Roffeei et al.
PHARMACOGENOMICS (2014)
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain
Eva J. Brandl et al.
PHARMACOGENOMICS (2014)
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist-protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
Pelle L. Ishoy et al.
BMJ OPEN (2014)
The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum
Melkaye G. Melka et al.
CLINICAL EPIGENETICS (2014)
Weight Loss Intervention for Individuals with Diabetes and Serious Mental Illness: A Pragmatic Experiment in Community Settings
Rohan Ganguli et al.
Canadian Journal of Diabetes (2013)
The pharmacogenetics of antipsychotic-induced adverse events
Daniel J. Mueller et al.
CURRENT OPINION IN PSYCHIATRY (2013)
Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways
Maja Pijet et al.
CYTOKINE (2013)
Finite mixture regression model analysis on antipsychotics induced weight gain: Investigation of the role of the serotonergic genes
Behdin Nowrouzi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain
Eva J. Brandl et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
Gavin P. Reynolds et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
Fabian Czerwensky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients
Arun K. Tiwari et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Polymorphisms of the Histamine Receptor (H1HR) Gene Are Not Associated With Olanzapine-Induced Weight Gain
Beata R. Godlewska et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Association of the Common MC4R rs17782313 Polymorphism With Antipsychotic-Related Weight Gain
Fabian Czerwensky et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
A Glucose Eater Drug as a Therapeutic Agent in Psychiatry
Robert H. Howland
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2013)
Detection of Metabolic Syndrome in Schizophrenia and Implications for Antipsychotic Therapy Is There a Role for Folate?
Kyle J. Burghardt et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Genetics of antipsychotic-induced weight gain: update and current perspectives
Amy C. C. Kao et al.
PHARMACOGENOMICS (2013)
The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia
S. A. Lott et al.
PHARMACOGENOMICS JOURNAL (2013)
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
B. Almoguera et al.
PHARMACOGENOMICS JOURNAL (2013)
Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
N. I. Chowdhury et al.
PHARMACOGENOMICS JOURNAL (2013)
Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population
Xiaofeng Hu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
E. L. Nurmi et al.
TRANSLATIONAL PSYCHIATRY (2013)
Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy
C. Anthony Altar et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
Regulation of Glucose Transporter Translocation in Health and Diabetes
Jonathan S. Bogan
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug-Induced Weight Gain
Anil K. Malhotra et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
T. A. P. Lett et al.
MOLECULAR PSYCHIATRY (2012)
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
E. J. Brandl et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences
Kyle J. Burghardt et al.
EPIGENOMICS (2012)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
M. A. Febbraio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
S. Gebhardt et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia
Maria del Rosario Garcia-Miss et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight
Jessica Bah et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
Arun K. Tiwari et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis
Michelle N. Sicard et al.
PHARMACOGENOMICS (2010)
What Is Epigenetics? INTRODUCTION
Guy Riddihough et al.
SCIENCE (2010)
Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
Bart P. F. Rutten et al.
SCHIZOPHRENIA BULLETIN (2009)
Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment
J. Minet-Ringuet et al.
MOLECULAR PSYCHIATRY (2007)
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
Timothy M. Frayling et al.
SCIENCE (2007)
Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia
Joseph Levine et al.
BIOLOGICAL PSYCHIATRY (2006)
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis
JW Muntjewerff et al.
MOLECULAR PSYCHIATRY (2006)
Genetics of antipsychotic treatment emergent weight gain in schizophrenia
Daniel J. Mueller et al.
PHARMACOGENOMICS (2006)
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
KM Gamber et al.
NEUROPHARMACOLOGY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pharmacogenetics of antipsychotic-induced weight gain
DJ Müller et al.
PHARMACOLOGICAL RESEARCH (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
MTHFR 677C→T polymorphism and risk of coronary heart disease -: A meta-analysis
M Klerk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion
B Vozarova et al.
OBESITY RESEARCH (2001)
Share Paper
